z-logo
open-access-imgOpen Access
Role of Helicobacter pylori Eradication Using Clarithromycin-based Triple Therapy in Patients with Irritable Bowel Syndrome.
Author(s) -
Haidi KaramAllah Ramadan,
Gellan K. Ahmed,
Waleed Attia Hassan
Publication year - 2022
Publication title -
bulletin of pharmaceutical sciences assiut
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.102
H-Index - 8
eISSN - 3009-7703
pISSN - 1110-0052
DOI - 10.21608/bfsa.2022.140045.1385
Subject(s) - irritable bowel syndrome , clarithromycin , helicobacter pylori , medicine , gastroenterology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom